Los Angeles Capital Management LLC Sage Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $29.2 Billion
- Q1 2024
A detailed history of Los Angeles Capital Management LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 15,348 shares of SAGE stock, worth $165,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,348
Previous 15,348
-0.0%
Holding current value
$165,451
Previous $332,000
13.55%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SAGE
# of Institutions
222Shares Held
52.7MCall Options Held
207KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA5.75MShares$62 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$59.1 Million1.65% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$52.7 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.75MShares$51.2 Million0.02% of portfolio
-
State Street Corp Boston, MA4.49MShares$48.5 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $641M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...